Skip to main content
. 2017 Mar 8;12:1853–1862. doi: 10.2147/IJN.S131235

Table 1.

Characterization of drug-loaded LPNPs

Samples Size (nm) PDI EE (%) LE (%) Zeta potential (mV)
DOX-LPNPs 111±7 0.10±0.03 80.2±0.3 6.2±0.5 −5.4±0.5
TPL-LPNPs 108±6 0.09±0.03 71.3±0.4 2.9±0.3 −15.7±1.5
DOX/TPL-1/0.2 120±5 0.12±0.04 75.5±0.5 (DOX) 5.3±0.3 (DOX) −9.7±0.8
58.3±0.4 (TPL) 1.1±0.1 (TPL)

Abbreviations: DOX, doxorubicin; EE, encapsulation efficiency; LE, loading efficiency; LPNPs, lipid–polymer hybrid nanoparticles; PDI, polydispersity index; TPL, triptolide.